XL019

Inquiry

Cat. No.: DIA-0230038

Size: 50 mg Size: 500 mg Size: Customer Size

Product Information
CAS No.	945755-56-6
Formula	C₂₅H₂₈N₆O₂
Molecular Weight	444.53
SMILES	O=C(NC1=CC=C(C=C1)C2=CC=NC(=N2)NC3=CC=C(C=C3)N4CCOCC4)C5CCCN5
Target	JAK2
Product Description	XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, exhibiting >50-fold selectivity over JAK1, JAK3 and TYK2. Phase 1.

Format & Storage
Purity	> 99%
Shipping	Shipped on dry ice.
Storage	Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview	Soluble in DMSO

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Top